Question 1

What are the most cited papers from Cancéropôle Est?

Accepted Answer

The most cited paper from Cancéropôle Est is "The SRA protein UHRF1 promotes epigenetic crosstalks and is involved in prostate cancer progression" (Federica Babbio, Christian Pistore, Laura Curti et al., 2012), with 137 citations. Next come "The PHD Domain of Np95 (mUHRF1) Is Involved in Large-Scale Reorganization of Pericentromeric Heterochromatin" (69) and "Development and validation of the FRAGIRE tool for assessment an older person’s risk for frailty" (43).

Question 2

Which research topics does Cancéropôle Est publish most on?

Accepted Answer

By volume in 2022-now: Colorectal and Anal Carcinomas, Pancreatic and Hepatic Oncology Research, Cancer Genomics and Diagnostics and Immune Cell Function and Interaction.

Question 3

Which fields of science does Cancéropôle Est work in?

Accepted Answer

In all years, 53% of research at Cancéropôle Est is in Health Sciences, 40% in Life Sciences. Its largest fields are Medicine (47%), Biochemistry, Genetics and Molecular Biology (27%), Agricultural and Biological Sciences (7%).

Question 4

Is Cancéropôle Est's research output growing?

Accepted Answer

Output in 2022-2025 was 42% higher than in 2018-2021.